Jacky-Mo
ActiveFrom the official registers: KBO 21 annual accounts at the National Bank publications in the Belgian Official Gazette
Summary
Jacky-Mo has been active since 2004 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €448,397 and a net result of €12,441. Equity is growing by about 9.4% per year across the filed financial years. Its solvency ranks better than 86% of 5,034 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.4% (very low).
History
Acts, filings and financial milestones
Next filing, financial year 2026, expected by
2026
31-08
financial year 2025 · full format · 31 days late
01-04
Gazette deed
Purpose · Amendment of the articles · NameName change · Purpose change · Power of attorney6 facts ▸
Gazette deed
Purpose · Amendment of the articles · Name
Name change · Purpose change · Power of attorney6 facts ▸
- General meeting, 27-03-2026
- Name change, Jacky-Mo
- Other provision, “dispense de lecture du rapport de l'organe d'administration, lecture par la présidente” (deed in French)
- Other provision, “réception et connaissance du rapport de l'organe d'administration, tous les actionnaires présents” (deed in French)
- Purpose change
- Power of attorney, Régis Dechamps
2025
31-12
Financial
Back to profitnet €12,441
Net result €12,441 after one loss-making year.
02-06
financial year 2024 · full format
2024
31-12
Financial
Weakest financial yearnet -€870
Net result drops to -€870, the lowest in the series; recovery starts the following year.
25-06
financial year 2023 · full format
2023
31-12
Financial
Highest result from 2018 to 2025net €149,080 ▲217%
Operating result €198,902, net result €149,080, both a record.
31-12
Financial
Liquidity more than 17 timescurrent ratio 198.36
Current ratio from 11.33 to 198.36; short-term debt falls from €29,643 to €2,559.
30-06
financial year 2022 · micro format
10-03
Gazette deed
Resignation: Marie Françoise MORLIGHEM (director)Appointment: VDV Pharma SRL (director) · Permanent representative: Julie PYLS · Director discharge7 facts ▸
Gazette deed
Resignation: Marie Françoise MORLIGHEM (director)
Appointment: VDV Pharma SRL (director) · Permanent representative: Julie PYLS · Director discharge7 facts ▸
- General meeting, 31-12-2022
- Director resignation, Marie Françoise MORLIGHEM (director)
- Director discharge, Marie Françoise MORLIGHEM (director) (2 times)
- Director appointment, VDV Pharma SRL (director)
- Permanent representative, Julie PYLS
- Board meeting, 31-12-2022
- Registered-office move, Chaussée de Helmet 373 à 1030 Schaerbeek
2022
31-12
Financial
Liquidity more than doubledcurrent ratio 11.33
Current ratio from 5.45 to 11.33; short-term debt falls from €84,899 to €29,643.
13-07
financial year 2021 · full format
Show earlier events
2021
24-06
financial year 2020 · full format
2020
10-07
financial year 2019 · micro format
2019
30-07
financial year 2018 · micro format
2018
29-06
financial year 2017 · micro format
2017
30-06
financial year 2016 · micro format
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
Sources:Publications in the Belgian Official GazetteFilings with the National Bank